Patents Assigned to Urquima S.A.
  • Patent number: 10421719
    Abstract: The present invention relates to a salt of formula (I), the preparation method for preparing same, and the use thereof in the preparation of silodosin.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: September 24, 2019
    Assignee: URQUIMA S.A.
    Inventors: José Luis Del Río Pericacho, Xavier Vila Tusell
  • Patent number: 10221141
    Abstract: A method for the preparation of purified ivabradine and salts thereof, a method for the purification of ivabradine and salts thereof, a new reactant used in said methods and the use of said reactant for the preparation of ivabradine.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: March 5, 2019
    Assignee: URQUIMA, S.A.
    Inventors: José Luis Del Río Pericacho, Yolanda Arredondo Martínez
  • Publication number: 20180162820
    Abstract: A method for the preparation of purified ivabradine and salts thereof, a method for the purification of ivabradine and salts thereof, a new reactant used in said methods and the use of said reactant for the preparation of ivabradine.
    Type: Application
    Filed: June 2, 2016
    Publication date: June 14, 2018
    Applicant: URQUIMA, S.A
    Inventors: José Luis DEL RÍO PERICACHO, Yolanda ARREDONDO MARTÍNEZ
  • Patent number: 9309201
    Abstract: Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient and pharmaceutical compositions containing Ivabradine hydrochloride Form IV.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: April 12, 2016
    Assignee: URQUIMA, S.A.
    Inventors: Rafael Prohens Lopez, Cristina Puigjaner Vallet, Rafael Barbas Canero, Jose Luis Del Rio Pericacho, Josep Marti Via
  • Publication number: 20150344435
    Abstract: Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient and pharmaceutical compositions containing lvabradine hydrochloride Form IV.
    Type: Application
    Filed: July 22, 2015
    Publication date: December 3, 2015
    Applicant: URQUIMA, S.A.
    Inventors: Rafel Prohens Lopez, Cristina Puigjaner Vallet, Rafael Barbas Canero, Jose Luis Del Rio Pericacho, Josep Marti Via
  • Patent number: 9139531
    Abstract: Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: September 22, 2015
    Assignee: URQUIMA, S.A.
    Inventors: Rafel Prohens Lopez, Cristina Puigjaner Vallet, Rafael Barbas Canero, Jose Luis Del Rio Pericacho, Josep Marti Via
  • Publication number: 20110313044
    Abstract: The present invention is directed to a novel form of suberoylanilide hydroxamic acid and the processes for its preparation.
    Type: Application
    Filed: June 16, 2011
    Publication date: December 22, 2011
    Applicant: URQUIMA S.A.
    Inventors: Xavier Vila Tusell, Cristina Puigjaner Vallet, Rafel Prohens López, Anna Portell Bueso, Ismael Valverde Martin
  • Patent number: 7612219
    Abstract: Process for the preparation of olopatadine (I), which comprises reacting a compound of formula (V) in the presence of a palladium catalyst to provide a compound of formula (VI), wherein the acid protecting group is removed to provide the compound of formula (I) and if desired, transformation into its salts.
    Type: Grant
    Filed: July 11, 2005
    Date of Patent: November 3, 2009
    Assignee: Urquima S.A.
    Inventors: Joan Bosch Cartés, Jordi Bachs Roca, Antonia Ma Gomez Gomez, Yolanda Alonso Marin, Mercè Bessa Sanchez
  • Patent number: 7230118
    Abstract: A new process for the preparation of Ropinirole (1) and pharmaceutically acceptable hydrochloride salt thereof comprising reacting the compound (V) with nitromethane to obtain the compound of formula (II), which is reduced to compound (III) and alkylated to obtain compound (IV).
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: June 12, 2007
    Assignee: Urquima S.A.
    Inventors: Joan Bosch Cartés, Xavier Pujol Ollé, José Luis Del Rio Pericacho, Yolanda Alonso Marin, Mercè Bessa Sanchez
  • Patent number: 5932438
    Abstract: Thaumatins, protein sweeteners, are obtained through the expression of artificial, synthetic and substantially optimized genes, preferably in filamentous fungi such as Penicillium roquefortii, Aspergillus niger and Aspergillus niger var. awamori. Preparing substantially optimized artificial genes allows for high protein expression, making the process useful for industrial production of this valuable sweetener. Thaumatins may be obtained extracellularly and intracellularly. Intracellular production provides thaumatin-containing fungi that can be used per se in animal feed without prior separation of the fungal mycelium.
    Type: Grant
    Filed: April 21, 1995
    Date of Patent: August 3, 1999
    Assignee: Urquima, S.A.
    Inventors: Juan Uriach-Marsal, Victor Rubio-Susan, Cristina Patino-Martin, Eliza Iossif Kalo-Koenova, Catalina del Moral-Juarez, Ignacio Faus-Santasusana, Jose-Luis del Rio-Pericacho, Joan Blade-Pique